Kanagawa-ken, Japan

Mami Kawaguchi


Average Co-Inventor Count = 12.9

ph-index = 4

Forward Citations = 38(Granted Patents)


Location History:

  • Kanagawa-ken, JP (1997 - 2000)
  • Yokohama, JP (2002 - 2007)

Company Filing History:


Years Active: 1997-2007

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Mami Kawaguchi: Innovator in Antiallergic Agents

Introduction

Mami Kawaguchi is a prominent inventor based in Kanagawa-ken, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic agents. With a total of eight patents to her name, Kawaguchi's work has had a notable impact on medical science.

Latest Patents

Kawaguchi's latest patents include innovative compounds known as tricyclic triazolobenzazepine derivatives. These compounds are designed to serve as antiallergic agents and exhibit excellent bioavailability. The patents detail a process for producing these compounds, which involves several chemical reactions to create pharmacologically acceptable salts and solvates. The compounds are represented by specific formulas, showcasing her expertise in medicinal chemistry.

Career Highlights

Throughout her career, Mami Kawaguchi has worked with notable companies such as Meiji Seika Kabushiki Kaisha and Meiji Seika Kaisha, Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Kawaguchi has collaborated with esteemed colleagues, including Yasuo Ohtsuka and Takashi Shishikura. These partnerships have facilitated the exchange of ideas and fostered innovation in her research endeavors.

Conclusion

Mami Kawaguchi's contributions to the field of antiallergic agents through her patents and collaborations highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to influence the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…